Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

MRI-Guided Therapy Offers No Improvement Over Conventional Treat to Target for RA

  |  

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

References

ADVERTISEMENT
SCROLL TO CONTINUE
  1. Møller-Bisgaard S, Hørslev-Petersen K, Ejbjerg B, et al. Effect of magnetic resonance imaging vs. conventional treat-to-target strategies on disease activity remission and radiographic progression in rheumatoid arthritis: The IMAGINE-RA randomized clinical trial. JAMA. 2019 Feb 5;321(5):461–472.
  2. Haavardsholm EA, Aga AB, Olsen IC, et al. Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial. BMJ. 2016 Aug 16;354:i4205.
  3. Dale J, Stirling A, Zhang R, et al. Targeting ultrasound remission in early rheumatoid arthritis: the results of the TaSER study, a randomized clinical trial. Ann Rheum Dis. 2016 Jun;75(6):1043–1050.

Related Articles

    Target Remission

    Strategies to identify and track remission in your RA patients

    Imaging of Axial Psoriatic Arthritis

    The axial phenotype of psoriatic arthritis (axPsA) is an excellent example of a major controversy in rheumatology that has become the focus of attention because of the emergence of new therapies with different mechanisms of action for alleviating joint inflammation. It was first described in 1961 but, until recently, it has largely remained under the…